The WACC of Evelo Biosciences Inc (EVLO) is 8.1%.
| Range | Selected | |
| Cost of equity | 18,611.30% - 29,650.70% | 24,131.00% |
| Tax rate | 0.30% - 0.40% | 0.35% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.4% - 8.9% | 8.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 4045.09 | 5293.89 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 18,611.30% | 29,650.70% |
| Tax rate | 0.30% | 0.40% |
| Debt/Equity ratio | 7656.38 | 7656.38 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.4% | 8.9% |
| Selected WACC | 8.1% | |